Apple AirPods Pro 3 vs Otofonix Groove

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid available at $250, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This visible-in-ear device ranks #49 of 65 OTC hearing aids tested, placing it in the top 74% of its category. The standout performance area is music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during normal use. However, speech performance presents a more mixed picture: speech in quiet scores 2.3/5, falling 0.53 points below the category average, while speech in noise scores 1.8/5—above the category average but low in absolute terms. Own-voice comfort is a notable weakness at 1.9/5, scoring 0.61 points below the category average, which may affect how natural your own speech sounds while wearing the devices. The product showed meaningful improvement from tuning, with the normalized score rising from 3.2/5 to 3.8/5 after adjustment. The AirPods Pro 3 is best suited for users who prioritize music streaming quality and seamless Apple ecosystem integration over maximum speech clarity. Budget-conscious shoppers should note that several competitors in the same price range—including the Elehear Beyond and the previous-generation Apple AirPods Pro 2—achieved higher overall scores in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.